Koopmanschap M A, Rutten F F
Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands.
Pharmacoeconomics. 1996 Nov;10(5):460-6. doi: 10.2165/00019053-199610050-00003.
There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs. This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes. Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.
在经济评估中是否应将间接成本纳入考量可能存在一些争议,但对于估算这些成本的恰当方法肯定存在大量争论。本综述为量化和评估疾病的这些间接成本提供了实用指南,既适用于疾病总成本研究的总体层面,也适用于特定医疗保健项目的经济评估。文中考虑了两种计算这些成本的方法:传统的人力资本法和最近发展起来的摩擦成本法。前一种方法估算因疾病导致的生产损失的潜在价值,而后一种方法旨在考虑到经济中劳动力的稀缺程度,得出更现实的间接成本估算值。将详细描述和讨论估算过程中的所有必要步骤以及各阶段所需的数据。